| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.826 | 0.004 | 0.856 | Tumour necrosis factor alpha release inhibitor | 0.856 0.004 CID_154699639 0.778 0.004 CID_44250311 0.786 0.004 CID_154699796 | CID_154699639 | |
| 0.758 | 0.005 | 0.758 | Immunomodulator | 0.576 0.014 CID_154699639 0.659 0.007 CID_44250311 0.743 0.005 CID_154699796 | ||
| 0.606 | 0.003 | 0.606 | Interleukin 2 agonist | 0.512 0.007 CID_154699639 0.573 0.004 CID_44250311 0.566 0.004 CID_154699796 | ||
| 0.575 | 0.005 | 0.575 | Interleukin agonist | 0.445 0.013 CID_154699639 0.553 0.006 CID_44250311 0.487 0.01 CID_154699796 | ||
| 0.518 | 0.026 | 0.518 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.402 0.099 CID_154699639 0.382 0.117 CID_44250311 0.398 0.102 CID_154699796 | ||
| 0.486 | 0.004 | 0.486 | Cytokine production inhibitor | 0.168 0.05 CID_154699639 0.429 0.005 CID_44250311 0.256 0.022 CID_154699796 | ||
| 0.487 | 0.033 | 0.501 | Calcium channel L-type activator | 0.244 0.212 CID_154699639 0.501 0.027 CID_44250311 0.41 0.074 CID_154699796 | CID_44250311 | |
| 0.427 | 0.003 | 0.427 | Interleukin 2 antagonist | 0.235 0.005 CID_154699639 0.331 0.004 CID_44250311 0.377 0.004 CID_154699796 | ||
| 0.42 | 0.005 | 0.436 | Tumour necrosis factor antagonist | 0.348 0.011 CID_154699639 0.436 0.005 CID_44250311 0.299 0.018 CID_154699796 | CID_44250311 | |
| 0.417 | 0.025 | 0.445 | DNA damaging | 0.296 0.059 CID_154699639 0.445 0.02 CID_44250311 0.343 0.043 CID_154699796 | CID_44250311 | |
| 0.407 | 0.02 | 0.407 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.352 0.035 CID_154699639 0.352 0.035 CID_44250311 0.261 0.096 CID_154699796 | ||
| 0.479 | 0.097 | 0.553 | Antiinflammatory | 0.467 0.102 CID_154699639 0.524 0.078 CID_44250311 0.553 0.067 CID_154699796 | CID_154699796 | |
| 0.384 | 0.004 | 0.384 | Interleukin 12 antagonist | 0.164 0.009 CID_154699639 0.336 0.004 CID_44250311 0.239 0.005 CID_154699796 | ||
| 0.432 | 0.093 | 0.521 | Caspase 9 stimulant | 0.394 0.115 CID_154699639 0.521 0.052 CID_44250311 0.414 0.103 CID_154699796 | CID_44250311 | |
| 0.386 | 0.06 | 0.391 | Vasodilator, peripheral | 0.294 0.1 CID_154699639 0.391 0.058 CID_44250311 0.279 0.108 CID_154699796 | CID_44250311 | |
| 0.332 | 0.015 | 0.332 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.279 0.037 CID_154699639 0.273 0.042 CID_44250311 0.279 0.037 CID_154699796 | ||
| 0.337 | 0.036 | 0.367 | Angiogenesis stimulant | 0.367 0.028 CID_154699639 0.353 0.032 CID_44250311 0.297 0.051 CID_154699796 | CID_154699639 | |
| 0.328 | 0.033 | 0.328 | 5 Hydroxytryptamine uptake stimulant | 0.324 0.034 CID_154699639 0.318 0.036 CID_44250311 0.266 0.067 CID_154699796 | ||
| 0.354 | 0.069 | 0.643 | Angiogenesis inhibitor | 0.643 0.013 CID_154699639 0.332 0.078 CID_44250311 0.256 0.118 CID_154699796 | CID_154699639 | |
| 0.303 | 0.02 | 0.303 | Lipocortins synthesis antagonist | 0.235 0.039 CID_154699639 0.296 0.022 CID_44250311 0.258 0.031 CID_154699796 | ||
| 0.362 | 0.08 | 0.362 | GABA C receptor rho-3 antagonist | 0.245 0.159 CID_154699639 0.357 0.082 CID_44250311 | ||
| 0.304 | 0.032 | 0.317 | Anesthetic general | 0.317 0.029 CID_154699639 0.311 0.03 CID_44250311 0.197 0.076 CID_154699796 | CID_154699639 | |
| 0.312 | 0.04 | 0.332 | DNA synthesis inhibitor | 0.313 0.039 CID_154699639 0.332 0.034 CID_44250311 0.313 0.039 CID_154699796 | CID_44250311 | |
| 0.303 | 0.057 | 0.308 | Insulysin inhibitor | 0.197 0.161 CID_154699639 0.308 0.054 CID_44250311 0.189 0.174 CID_154699796 | CID_44250311 | |
| 0.248 | 0.004 | 0.256 | Phosphodiesterase 6D inhibitor | 0.173 0.006 CID_154699639 0.256 0.003 CID_44250311 0.171 0.006 CID_154699796 | CID_44250311 | |
| 0.245 | 0.006 | 0.245 | 5 Hydroxytryptamine 3A agonist | 0.136 0.044 CID_154699639 0.233 0.008 CID_44250311 0.14 0.041 CID_154699796 | ||
| 0.311 | 0.081 | 0.311 | Calcium channel activator | 0.216 0.19 CID_154699639 0.285 0.107 CID_44250311 0.232 0.169 CID_154699796 | ||
| 0.276 | 0.047 | 0.319 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 CID_154699639 0.319 0.025 CID_44250311 0.19 0.154 CID_154699796 | CID_44250311 | |
| 0.274 | 0.05 | 0.274 | Psychostimulant | 0.139 0.126 CID_154699639 0.243 0.061 CID_44250311 0.227 0.067 CID_154699796 | ||
| 0.269 | 0.055 | 0.321 | Interleukin antagonist | 0.135 0.13 CID_154699639 0.321 0.043 CID_44250311 0.271 0.054 CID_154699796 | CID_44250311 | |
| 0.225 | 0.011 | 0.225 | Polo-like kinase-4 inhibitor | 0.126 0.051 CID_154699639 0.18 0.021 CID_44250311 0.148 0.037 CID_154699796 | ||
| 0.337 | 0.127 | 0.362 | 5 Hydroxytryptamine release inhibitor | 0.32 0.144 CID_154699639 0.362 0.105 CID_44250311 | CID_44250311 | |
| 0.222 | 0.015 | 0.222 | MAP kinase kinase 5 inhibitor | 0.188 0.048 CID_154699639 0.187 0.051 CID_44250311 0.191 0.044 CID_154699796 | ||
| 0.254 | 0.05 | 0.254 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.159 0.116 CID_154699639 0.201 0.076 CID_44250311 | ||
| 0.226 | 0.027 | 0.379 | Alpha-N-acetylglucosaminidase inhibitor | 0.379 0.01 CID_154699639 0.175 0.043 CID_44250311 0.183 0.04 CID_154699796 | CID_154699639 | |
| 0.293 | 0.098 | 0.43 | Transcription factor NF kappa B inhibitor | 0.268 0.114 CID_154699639 0.43 0.057 CID_44250311 0.372 0.07 CID_154699796 | CID_44250311 | |
| 0.313 | 0.123 | 0.313 | MAP kinase kinase 6 inhibitor | 0.266 0.171 CID_154699639 0.239 0.205 CID_44250311 | ||
| 0.247 | 0.061 | 0.247 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.154 CID_154699639 0.24 0.066 CID_44250311 | ||
| 0.267 | 0.09 | 0.299 | Immunostimulant | 0.261 0.092 CID_154699639 0.299 0.079 CID_44250311 0.257 0.093 CID_154699796 | CID_44250311 | |
| 0.298 | 0.125 | 0.399 | Histamine release inhibitor | 0.217 0.183 CID_154699639 0.399 0.076 CID_44250311 | CID_44250311 | |
| 0.177 | 0.009 | 0.177 | Cyclin B3 inhibitor | 0.162 0.011 CID_44250311 0.092 0.032 CID_154699796 | ||
| 0.163 | 0.006 | 0.163 | CDK4/cyclin D1 inhibitor | 0.084 0.022 CID_154699639 0.118 0.011 CID_44250311 0.087 0.02 CID_154699796 | ||
| 0.191 | 0.034 | 0.265 | Cholinergic antagonist | 0.127 0.067 CID_154699639 0.17 0.043 CID_44250311 0.265 0.018 CID_154699796 | CID_154699796 | |
| 0.189 | 0.034 | 0.259 | Acetylcholine antagonist | 0.124 0.067 CID_154699639 0.168 0.041 CID_44250311 0.259 0.019 CID_154699796 | CID_154699796 | |
| 0.198 | 0.042 | 0.205 | Interleukin 6 antagonist | 0.161 0.073 CID_154699639 0.205 0.038 CID_44250311 0.186 0.05 CID_154699796 | CID_44250311 | |
| 0.185 | 0.031 | 0.213 | Alkylator | 0.159 0.042 CID_154699639 0.213 0.023 CID_44250311 0.161 0.041 CID_154699796 | CID_44250311 | |
| 0.16 | 0.006 | 0.16 | Bromodomain-containing protein 2 inhibitor | 0.131 0.017 CID_44250311 0.098 0.043 CID_154699796 | ||
| 0.293 | 0.141 | 0.414 | Antibacterial | 0.407 0.073 CID_154699639 0.349 0.102 CID_44250311 0.414 0.07 CID_154699796 | CID_154699796 | |
| 0.157 | 0.006 | 0.157 | Phosphodiesterase VI inhibitor | 0.094 0.024 CID_154699639 0.153 0.006 CID_44250311 0.094 0.024 CID_154699796 | ||
| 0.185 | 0.037 | 0.225 | Cell wall synthesis inhibitor | 0.225 0.022 CID_154699639 0.195 0.032 CID_44250311 0.17 0.048 CID_154699796 | CID_154699639 | |
| 0.173 | 0.026 | 0.173 | Nav1.4 sodium channel blocker | 0.154 0.032 CID_154699639 0.169 0.027 CID_44250311 0.138 0.039 CID_154699796 | ||
| 0.216 | 0.078 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.25 0.049 CID_154699639 0.226 0.067 CID_44250311 0.187 0.121 CID_154699796 | CID_154699639 | |
| 0.146 | 0.012 | 0.146 | Cyclin-dependent kinase 4 inhibitor | 0.059 0.053 CID_154699639 0.102 0.025 CID_44250311 0.092 0.029 CID_154699796 | ||
| 0.163 | 0.029 | 0.163 | GABA C receptor agonist | 0.14 0.038 CID_154699639 0.136 0.04 CID_44250311 0.096 0.071 CID_154699796 | ||
| 0.231 | 0.099 | 0.25 | 5 Hydroxytryptamine release stimulant | 0.216 0.109 CID_154699639 0.25 0.089 CID_44250311 | CID_44250311 | |
| 0.18 | 0.05 | 0.212 | Neurotensin receptor agonist | 0.212 0.03 CID_44250311 | CID_44250311 | |
| 0.22 | 0.095 | 0.22 | Calpain inhibitor | 0.173 0.144 CID_44250311 | ||
| 0.133 | 0.009 | 0.133 | Protein kinase C eta inhibitor | 0.125 0.011 CID_154699639 0.129 0.01 CID_44250311 0.094 0.019 CID_154699796 | ||
| 0.183 | 0.062 | 0.183 | Antipruritic | 0.182 0.063 CID_44250311 | ||
| 0.135 | 0.014 | 0.135 | Phosphodiesterase 11A inhibitor | 0.081 0.057 CID_154699639 0.1 0.032 CID_44250311 0.079 0.061 CID_154699796 | ||
| 0.135 | 0.014 | 0.135 | Phosphodiesterase XI inhibitor | 0.081 0.057 CID_154699639 0.1 0.032 CID_44250311 0.079 0.061 CID_154699796 | ||
| 0.137 | 0.017 | 0.137 | Somatostatin 1 agonist | 0.121 0.023 CID_154699639 0.136 0.017 CID_44250311 0.108 0.029 CID_154699796 | ||
| 0.142 | 0.023 | 0.162 | Anabolic | 0.147 0.019 CID_154699639 0.162 0.012 CID_44250311 0.125 0.035 CID_154699796 | CID_44250311 | |
| 0.188 | 0.069 | 0.188 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.139 0.096 CID_44250311 | ||
| 0.126 | 0.009 | 0.126 | CDK4/cyclin D inhibitor | 0.06 0.039 CID_154699639 0.086 0.019 CID_44250311 0.063 0.034 CID_154699796 | ||
| 0.14 | 0.023 | 0.164 | Triose-phosphate isomerase inhibitor | 0.164 0.016 CID_154699639 0.118 0.033 CID_44250311 0.103 0.045 CID_154699796 | CID_154699639 | |
| 0.14 | 0.025 | 0.14 | Acetylcholine M3 receptor agonist | 0.126 0.031 CID_154699796 | ||
| 0.128 | 0.015 | 0.128 | CXC chemokine receptor antagonist | 0.087 0.032 CID_44250311 | ||
| 0.193 | 0.079 | 0.193 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.148 0.114 CID_44250311 | ||
| 0.214 | 0.109 | 0.249 | Spasmolytic | 0.165 0.15 CID_154699639 0.249 0.091 CID_44250311 0.175 0.141 CID_154699796 | CID_44250311 | |
| 0.133 | 0.027 | 0.133 | Electrolyte absorption antagonist | 0.092 0.071 CID_154699639 0.097 0.062 CID_44250311 | ||
| 0.111 | 0.007 | 0.111 | Poly(ADP-ribose) polymerase inhibitor | 0.048 0.026 CID_44250311 | ||
| 0.11 | 0.009 | 0.114 | Oxytocin antagonist | 0.114 0.009 CID_154699639 0.058 0.015 CID_44250311 0.039 0.025 CID_154699796 | CID_154699639 | |
| 0.126 | 0.028 | 0.165 | Acetylcholine nicotinic antagonist | 0.072 0.066 CID_154699639 0.097 0.041 CID_44250311 0.165 0.017 CID_154699796 | CID_154699796 | |
| 0.12 | 0.022 | 0.12 | Hematopoietic | 0.105 0.031 CID_44250311 0.087 0.056 CID_154699796 | ||
| 0.139 | 0.042 | 0.139 | Ferrochelatase inhibitor | 0.096 0.075 CID_154699639 | ||
| 0.128 | 0.033 | 0.161 | Prolactin inhibitor | 0.089 0.067 CID_154699639 0.161 0.018 CID_44250311 | CID_44250311 | |
| 0.155 | 0.062 | 0.155 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.185 | 0.092 | 0.185 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.21 | 0.119 | 0.21 | 5 Hydroxytryptamine 1E antagonist | 0.208 0.122 CID_44250311 | ||
| 0.128 | 0.038 | 0.205 | UDP-glucose 4-epimerase inhibitor | 0.205 0.017 CID_154699639 0.125 0.04 CID_44250311 0.123 0.042 CID_154699796 | CID_154699639 | |
| 0.16 | 0.07 | 0.16 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.111 CID_44250311 | ||
| 0.151 | 0.063 | 0.154 | Neuropeptide Y1 antagonist | 0.154 0.059 CID_44250311 | CID_44250311 | |
| 0.114 | 0.027 | 0.114 | Factor XII inhibitor | 0.083 0.061 CID_154699639 0.099 0.038 CID_44250311 0.089 0.05 CID_154699796 | ||
| 0.128 | 0.043 | 0.172 | Nav1.1 sodium channel blocker | 0.087 0.085 CID_154699639 0.12 0.048 CID_44250311 0.172 0.026 CID_154699796 | CID_154699796 | |
| 0.098 | 0.013 | 0.098 | Antidiuretic hormone antagonist | 0.053 0.022 CID_154699639 0.039 0.028 CID_44250311 | ||
| 0.135 | 0.052 | 0.135 | Glycogen synthase kinase-3 inhibitor | |||
| 0.129 | 0.046 | 0.14 | Protein kinase C gamma inhibitor | 0.105 0.069 CID_154699639 0.14 0.038 CID_44250311 | CID_44250311 | |
| 0.09 | 0.008 | 0.09 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.029 CID_44250311 | ||
| 0.152 | 0.071 | 0.152 | GABA C receptor rho-2 antagonist | 0.145 0.081 CID_44250311 | ||
| 0.114 | 0.034 | 0.114 | Polo-like kinase-1 inhibitor | 0.084 0.075 CID_44250311 | ||
| 0.134 | 0.055 | 0.134 | Proteasome inhibitor | 0.119 0.066 CID_44250311 0.113 0.072 CID_154699796 | ||
| 0.142 | 0.066 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.156 0.031 CID_154699639 0.137 0.085 CID_44250311 0.14 0.072 CID_154699796 | CID_154699639 | |
| 0.083 | 0.008 | 0.083 | Antiviral (Hepatitis D) | 0.069 0.014 CID_154699639 0.071 0.013 CID_44250311 0.066 0.017 CID_154699796 | ||
| 0.092 | 0.018 | 0.092 | 5 Hydroxytryptamine 2A agonist | 0.089 0.02 CID_44250311 | ||
| 0.096 | 0.024 | 0.096 | Protein kinase C alpha inhibitor | 0.067 0.048 CID_154699639 0.074 0.04 CID_44250311 | ||
| 0.079 | 0.008 | 0.079 | Vasopressin 2 antagonist | 0.045 0.016 CID_154699639 0.043 0.017 CID_44250311 0.03 0.026 CID_154699796 | ||
| 0.085 | 0.015 | 0.085 | MDM2 inhibitor | 0.073 0.031 CID_154699639 0.067 0.047 CID_44250311 0.068 0.045 CID_154699796 | ||
| 0.1 | 0.032 | 0.112 | Glycine receptor antagonist | 0.112 0.023 CID_154699639 0.079 0.059 CID_44250311 0.099 0.033 CID_154699796 | CID_154699639 | |
| 0.108 | 0.04 | 0.108 | Alpha 1 adrenoreceptor antagonist | 0.077 0.055 CID_44250311 | ||
| 0.088 | 0.021 | 0.088 | Acetylcholine M5 receptor antagonist | 0.068 0.033 CID_44250311 0.059 0.044 CID_154699796 | ||
| 0.181 | 0.114 | 0.207 | ErbB-1 antagonist | 0.207 0.082 CID_44250311 | CID_44250311 | |
| 0.113 | 0.047 | 0.113 | GABA C receptor rho-1 antagonist | 0.098 0.065 CID_44250311 | ||
| 0.113 | 0.047 | 0.113 | Insulin receptor antagonist | |||
| 0.112 | 0.047 | 0.112 | Protein kinase C mu inhibitor | 0.1 0.057 CID_154699639 0.096 0.061 CID_44250311 | ||
| 0.121 | 0.056 | 0.121 | GABA receptor agonist | |||
| 0.139 | 0.077 | 0.148 | Heat shock protein 70 antagonist | 0.147 0.052 CID_154699639 0.148 0.051 CID_44250311 | CID_44250311 | |
| 0.117 | 0.054 | 0.117 | Acetylcholine release stimulant | |||
| 0.089 | 0.027 | 0.089 | Acetylcholine M5 receptor agonist | 0.06 0.056 CID_154699796 | ||
| 0.085 | 0.024 | 0.085 | Protein kinase C beta inhibitor | 0.073 0.041 CID_154699639 0.083 0.026 CID_44250311 | ||
| 0.071 | 0.009 | 0.071 | Vasopressin 1A antagonist | 0.056 0.012 CID_154699639 0.029 0.02 CID_44250311 | ||
| 0.071 | 0.012 | 0.071 | Vasopressin 1 antagonist | 0.048 0.015 CID_154699639 0.031 0.024 CID_44250311 | ||
| 0.12 | 0.061 | 0.12 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.109 | 0.05 | 0.194 | Creatine kinase inhibitor | 0.12 0.041 CID_154699639 0.194 0.012 CID_44250311 | CID_44250311 | |
| 0.117 | 0.058 | 0.117 | Nav1.5 sodium channel blocker | |||
| 0.122 | 0.065 | 0.122 | Acetylcholine muscarinic antagonist | 0.111 0.078 CID_44250311 0.097 0.095 CID_154699796 | ||
| 0.084 | 0.027 | 0.084 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.085 | 0.028 | 0.085 | Phospholipase D inhibitor | 0.078 0.037 CID_154699639 0.066 0.062 CID_154699796 | ||
| 0.066 | 0.01 | 0.066 | Nicotinic receptor beta4 subunit antagonist | 0.044 0.019 CID_154699639 0.058 0.013 CID_44250311 0.044 0.02 CID_154699796 | ||
| 0.107 | 0.053 | 0.107 | Alpha adrenoreceptor antagonist | 0.087 0.066 CID_44250311 | ||
| 0.059 | 0.005 | 0.059 | Protein kinase C beta II inhibitor | 0.048 0.007 CID_154699639 0.053 0.005 CID_44250311 0.042 0.01 CID_154699796 | ||
| 0.259 | 0.205 | 0.561 | Apoptosis agonist | 0.277 0.19 CID_154699639 0.388 0.119 CID_44250311 0.561 0.058 CID_154699796 | CID_154699796 | |
| 0.118 | 0.066 | 0.118 | 5 Hydroxytryptamine antagonist | |||
| 0.084 | 0.033 | 0.109 | Neuronal nicotinic receptor antagonist | 0.066 0.048 CID_44250311 0.109 0.021 CID_154699796 | CID_154699796 | |
| 0.089 | 0.038 | 0.089 | Cathepsin G inhibitor | 0.074 0.049 CID_44250311 | ||
| 0.185 | 0.135 | 0.225 | Superoxide dismutase inhibitor | 0.225 0.093 CID_44250311 | CID_44250311 | |
| 0.062 | 0.011 | 0.062 | Histone deacetylase 9 inhibitor | 0.042 0.023 CID_44250311 | ||
| 0.179 | 0.13 | 0.206 | Nitric-oxide synthase stimulant | 0.202 0.086 CID_154699639 0.206 0.079 CID_44250311 0.17 0.153 CID_154699796 | CID_44250311 | |
| 0.09 | 0.04 | 0.09 | Alpha 1a adrenoreceptor antagonist | 0.061 0.057 CID_44250311 | ||
| 0.066 | 0.017 | 0.066 | HCV NS3/NS4A protease inhibitor | 0.063 0.019 CID_154699639 0.05 0.033 CID_44250311 0.056 0.024 CID_154699796 | ||
| 0.074 | 0.027 | 0.074 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.17 | 0.123 | 0.195 | Cyclic AMP phosphodiesterase inhibitor | 0.195 0.098 CID_44250311 | CID_44250311 | |
| 0.089 | 0.043 | 0.12 | Thioredoxin reductase inhibitor | 0.089 0.042 CID_44250311 0.12 0.017 CID_154699796 | CID_154699796 | |
| 0.072 | 0.028 | 0.072 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.057 | 0.013 | 0.107 | Dopamine D5 agonist | 0.04 0.027 CID_154699639 0.107 0.004 CID_44250311 | CID_44250311 | |
| 0.129 | 0.086 | 0.129 | Activin receptor-like kinase 2 inhibitor | 0.112 0.106 CID_44250311 | ||
| 0.097 | 0.054 | 0.097 | CDK/cyclin complex inhibitor | |||
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.07 | 0.028 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.108 | 0.066 | 0.108 | GABA C receptor antagonist | 0.098 0.081 CID_44250311 | ||
| 0.054 | 0.012 | 0.054 | Histone deacetylase class IV inhibitor | 0.038 0.018 CID_44250311 0.033 0.021 CID_154699796 | ||
| 0.054 | 0.012 | 0.054 | Histone deacetylase 11 inhibitor | 0.038 0.018 CID_44250311 0.033 0.021 CID_154699796 | ||
| 0.066 | 0.024 | 0.066 | Nicotinic receptor alpha7 subunit antagonist | 0.061 0.028 CID_154699796 | ||
| 0.046 | 0.005 | 0.046 | Protein kinase C beta I inhibitor | 0.044 0.005 CID_154699639 0.044 0.005 CID_44250311 0.039 0.01 CID_154699796 | ||
| 0.075 | 0.035 | 0.075 | Glutamate (mGluR7) antagonist | 0.068 0.047 CID_44250311 | ||
| 0.052 | 0.012 | 0.052 | 5 Hydroxytryptamine 2B agonist | |||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | 0.04 0.036 CID_44250311 | ||
| 0.062 | 0.022 | 0.062 | Prolyl endopeptidase inhibitor | 0.052 0.034 CID_154699796 | ||
| 0.092 | 0.054 | 0.092 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.055 | 0.017 | 0.055 | Histone deacetylase 7 inhibitor | |||
| 0.064 | 0.028 | 0.064 | Protein kinase C epsilon inhibitor | 0.048 0.044 CID_44250311 | ||
| 0.064 | 0.029 | 0.064 | Bromodomain-containing protein 4 inhibitor | |||
| 0.156 | 0.121 | 0.156 | Focal adhesion kinase 2 inhibitor | |||
| 0.205 | 0.171 | 0.224 | Antithrombotic | 0.211 0.164 CID_154699639 0.224 0.15 CID_44250311 0.207 0.168 CID_154699796 | CID_44250311 | |
| 0.057 | 0.023 | 0.057 | Bromodomain-containing protein 3 inhibitor | |||
| 0.065 | 0.031 | 0.065 | Phosphodiesterase 1A inhibitor | |||
| 0.037 | 0.005 | 0.045 | 1,3-Beta-glucan synthase inhibitor | 0.045 0.003 CID_154699639 0.037 0.005 CID_44250311 0.035 0.007 CID_154699796 | CID_154699639 | |
| 0.099 | 0.067 | 0.099 | Alpha 2c adrenoreceptor antagonist | 0.084 0.082 CID_44250311 | ||
| 0.053 | 0.022 | 0.053 | Melanocortin 4 antagonist | |||
| 0.088 | 0.057 | 0.143 | Antineoplastic alkaloid | 0.143 0.03 CID_154699639 0.132 0.033 CID_44250311 0.095 0.051 CID_154699796 | CID_154699639 | |
| 0.097 | 0.066 | 0.097 | Glutamate (mGluR7) agonist | |||
| 0.055 | 0.024 | 0.055 | Melanocortin antagonist | |||
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 2 agonist | |||
| 0.044 | 0.014 | 0.044 | Histone deacetylase 10 inhibitor | 0.03 0.021 CID_44250311 | ||
| 0.061 | 0.031 | 0.061 | Cyclin B2 inhibitor | 0.061 0.031 CID_44250311 | ||
| 0.053 | 0.023 | 0.053 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.035 CID_44250311 | ||
| 0.11 | 0.081 | 0.11 | Cyclin-dependent kinase inhibitor | |||
| 0.065 | 0.037 | 0.065 | Cyclin B1 inhibitor | 0.065 0.038 CID_44250311 | ||
| 0.069 | 0.041 | 0.069 | Histone deacetylase inhibitor | |||
| 0.051 | 0.023 | 0.059 | Oxytocin agonist | 0.059 0.017 CID_44250311 | CID_44250311 | |
| 0.082 | 0.056 | 0.082 | Caspase 7 inhibitor | |||
| 0.057 | 0.031 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.038 CID_154699639 | ||
| 0.085 | 0.06 | 0.085 | Acetylcholine agonist | |||
| 0.041 | 0.017 | 0.041 | Histone deacetylase 4 inhibitor | 0.027 0.026 CID_44250311 | ||
| 0.038 | 0.015 | 0.038 | Adenosine uptake inhibitor | |||
| 0.096 | 0.073 | 0.176 | Topoisomerase I inhibitor | 0.109 0.063 CID_154699639 0.176 0.033 CID_44250311 | CID_44250311 | |
| 0.089 | 0.067 | 0.114 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.114 0.043 CID_154699639 | CID_154699639 | |
| 0.036 | 0.014 | 0.036 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.045 | 0.023 | 0.048 | DNA gyrase subunit A inhibitor | 0.048 0.019 CID_44250311 | CID_44250311 | |
| 0.046 | 0.025 | 0.046 | Histone deacetylase 8 inhibitor | |||
| 0.081 | 0.06 | 0.092 | CC chemokine 5 receptor agonist | 0.092 0.033 CID_44250311 | CID_44250311 | |
| 0.077 | 0.056 | 0.102 | MAP kinase kinase 7 inhibitor | 0.082 0.041 CID_154699639 0.102 0.011 CID_44250311 | CID_44250311 | |
| 0.045 | 0.026 | 0.045 | Growth hormone release inhibitor | 0.037 0.036 CID_154699639 0.043 0.028 CID_44250311 0.037 0.035 CID_154699796 | ||
| 0.04 | 0.021 | 0.04 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.047 | 0.03 | 0.047 | Glutamate (mGluR5) agonist | |||
| 0.042 | 0.026 | 0.042 | Kainate receptor agonist | 0.042 0.026 CID_154699639 | ||
| 0.106 | 0.089 | 0.106 | Glutamate receptor antagonist | 0.104 0.092 CID_44250311 | ||
| 0.103 | 0.086 | 0.134 | Microtubule formation inhibitor | 0.113 0.069 CID_154699639 0.101 0.09 CID_44250311 0.134 0.047 CID_154699796 | CID_154699796 | |
| 0.07 | 0.054 | 0.083 | Glycine receptor agonist | 0.083 0.034 CID_154699639 | CID_154699639 | |
| 0.07 | 0.055 | 0.07 | Catalase inhibitor | |||
| 0.071 | 0.056 | 0.071 | Acetylcholine M4 receptor antagonist | |||
| 0.033 | 0.019 | 0.033 | CXC chemokine 3 receptor antagonist | |||
| 0.053 | 0.038 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.02 CID_154699639 0.051 0.041 CID_154699796 | CID_154699639 | |
| 0.047 | 0.034 | 0.047 | Glutamate (mGluR group I) agonist | |||
| 0.037 | 0.023 | 0.037 | p53 inhibitor | |||
| 0.036 | 0.022 | 0.044 | Somatostatin 5 agonist | 0.044 0.016 CID_154699639 | CID_154699639 | |
| 0.033 | 0.019 | 0.033 | Acetylcholine M4 receptor agonist | |||
| 0.122 | 0.11 | 0.13 | MAP3K9 inhibitor | 0.13 0.094 CID_44250311 | CID_44250311 | |
| 0.041 | 0.029 | 0.041 | Neurokinin 2 antagonist | |||
| 0.067 | 0.054 | 0.117 | NMDA 2 receptor antagonist | 0.117 0.025 CID_44250311 | CID_44250311 | |
| 0.044 | 0.032 | 0.044 | 5 Hydroxytryptamine 2C agonist | |||
| 0.041 | 0.029 | 0.064 | Thymidine kinase inhibitor | 0.064 0.012 CID_154699639 | CID_154699639 | |
| 0.141 | 0.13 | 0.154 | Succinate dehydrogenase inhibitor | 0.154 0.105 CID_44250311 | CID_44250311 | |
| 0.082 | 0.07 | 0.083 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.068 CID_44250311 | CID_44250311 | |
| 0.057 | 0.046 | 0.057 | Cyclin A1 inhibitor | |||
| 0.031 | 0.021 | 0.031 | Dipeptidyl peptidase I inhibitor | |||
| 0.022 | 0.011 | 0.022 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.057 | 0.047 | 0.057 | Cyclin D1 inhibitor | |||
| 0.04 | 0.03 | 0.04 | Factor XIa inhibitor | |||
| 0.031 | 0.021 | 0.033 | Cyclophilin A inhibitor | 0.033 0.019 CID_154699639 | CID_154699639 | |
| 0.071 | 0.061 | 0.071 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.05 | 0.042 | 0.05 | Dipeptidyl peptidase inhibitor | |||
| 0.054 | 0.046 | 0.054 | Alpha 1d adrenoreceptor antagonist | |||
| 0.051 | 0.044 | 0.052 | Cyclin B inhibitor | 0.052 0.043 CID_44250311 | CID_44250311 | |
| 0.06 | 0.053 | 0.06 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.014 | 0.007 | 0.014 | Cyclin D2 inhibitor | |||
| 0.025 | 0.018 | 0.025 | Histone deacetylase class IIb inhibitor | |||
| 0.016 | 0.009 | 0.016 | CXC chemokine 4 receptor agonist | |||
| 0.025 | 0.018 | 0.025 | Histone deacetylase 6 inhibitor | |||
| 0.035 | 0.029 | 0.035 | Melanocortin 1 antagonist | |||
| 0.064 | 0.058 | 0.064 | Phosphodiesterase V inhibitor | |||
| 0.034 | 0.029 | 0.034 | 5-Alpha-reductase inhibitor | 0.034 0.03 CID_44250311 | ||
| 0.019 | 0.013 | 0.019 | Melatonin 3 antagonist | |||
| 0.026 | 0.021 | 0.026 | Melanocortin 3 antagonist | |||
| 0.049 | 0.044 | 0.049 | Acetylcholine M2 receptor agonist | |||
| 0.049 | 0.044 | 0.049 | Acetylcholine muscarinic agonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 5 antagonist | |||
| 0.062 | 0.059 | 0.062 | Glutamate (mGluR6) antagonist | 0.062 0.059 CID_154699639 | ||
| 0.037 | 0.034 | 0.037 | Glutamate (mGluR1a) antagonist | |||
| 0.048 | 0.045 | 0.048 | Phosphodiesterase 7A inhibitor | |||
| 0.041 | 0.038 | 0.054 | Mannosidase inhibitor | 0.054 0.022 CID_154699639 | CID_154699639 | |
| 0.08 | 0.077 | 0.08 | Phosphodiesterase I inhibitor | |||
| 0.025 | 0.023 | 0.025 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.068 | 0.066 | 0.074 | GABA aminotransferase inhibitor | 0.074 0.056 CID_44250311 | CID_44250311 | |
| 0.034 | 0.033 | 0.034 | Cyclin D3 inhibitor | |||
| 0.078 | 0.078 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.036 CID_154699639 0.084 0.067 CID_44250311 | CID_154699639 | |
| 0.15 | 0.15 | 0.205 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.205 0.068 CID_154699639 0.184 0.088 CID_44250311 | CID_154699639 | |
| 0.054 | 0.055 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.047 CID_44250311 | CID_44250311 | |
| 0.052 | 0.053 | 0.083 | Carbamoyl phosphate synthetase inhibitor | 0.083 0.027 CID_154699639 | CID_154699639 | |
| 0.135 | 0.138 | 0.331 | Antimitotic | 0.176 0.099 CID_44250311 0.331 0.037 CID_154699796 | CID_154699796 | |
| 0.196 | 0.201 | 0.419 | Immunosuppressant | 0.308 0.11 CID_154699639 0.239 0.157 CID_44250311 0.419 0.056 CID_154699796 | CID_154699796 | |
| 0.08 | 0.087 | 0.101 | Protein kinase C zeta inhibitor | 0.101 0.049 CID_44250311 | CID_44250311 | |
| 0.099 | 0.107 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.098 CID_44250311 | CID_44250311 | |
| 0.085 | 0.093 | 0.097 | DNA intercalator | 0.097 0.077 CID_44250311 | CID_44250311 | |
| 0.048 | 0.056 | 0.068 | Biliverdin reductase inhibitor | 0.068 0.034 CID_154699639 | CID_154699639 | |
| 0.029 | 0.039 | 0.033 | Kinesin antagonist | 0.033 0.031 CID_44250311 | CID_44250311 | |
| 0.029 | 0.039 | 0.033 | Kinesin-like protein 1 inhibitor | 0.033 0.031 CID_44250311 | CID_44250311 | |
| 0.031 | 0.041 | 0.035 | Erythropoietin receptor agonist | 0.035 0.034 CID_44250311 | CID_44250311 | |
| 0.07 | 0.08 | 0.111 | NMDA receptor antagonist | 0.111 0.04 CID_44250311 | CID_44250311 | |
| 0.042 | 0.052 | 0.055 | Topoisomerase II beta inhibitor | 0.055 0.027 CID_44250311 | CID_44250311 | |
| 0.036 | 0.048 | 0.045 | AICAR transformylase inhibitor | 0.045 0.029 CID_154699639 | CID_154699639 | |
| 0.049 | 0.062 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.043 CID_44250311 | CID_44250311 | |
| 0.023 | 0.036 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.01 CID_154699639 | CID_154699639 | |
| 0.007 | 0.02 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 CID_154699639 | CID_154699639 | |
| 0.031 | 0.045 | 0.052 | Dopamine D2 agonist | 0.052 0.025 CID_44250311 | CID_44250311 | |
| 0.019 | 0.033 | 0.031 | Uridine phosphorylase inhibitor | 0.031 0.017 CID_154699639 | CID_154699639 | |
| 0.047 | 0.062 | 0.071 | Androgen agonist | 0.071 0.03 CID_154699639 0.066 0.034 CID_44250311 | CID_154699639 | |
| 0.117 | 0.133 | 0.147 | Adenylate cyclase stimulant | 0.147 0.068 CID_154699639 0.141 0.079 CID_44250311 | CID_154699639 | |
| 0.016 | 0.033 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 CID_154699639 | CID_154699639 | |
| 0.066 | 0.084 | 0.101 | Androgen antagonist | 0.101 0.046 CID_154699639 0.095 0.05 CID_44250311 | CID_154699639 | |
| 0.113 | 0.131 | 0.18 | NOS3 expression enhancer | 0.18 0.05 CID_44250311 | CID_44250311 | |
| 0.042 | 0.061 | 0.068 | NMDA 2B receptor antagonist | 0.068 0.026 CID_44250311 | CID_44250311 | |
| 0.041 | 0.061 | 0.064 | Argininosuccinate synthase inhibitor | 0.064 0.034 CID_154699639 | CID_154699639 | |
| 0.102 | 0.122 | 0.263 | Peroxidase inhibitor | 0.263 0.045 CID_44250311 | CID_44250311 | |
| 0.11 | 0.131 | 0.133 | Sigma receptor agonist | 0.133 0.099 CID_44250311 | CID_44250311 | |
| 0.036 | 0.058 | 0.067 | Aldose reductase inhibitor | 0.067 0.028 CID_44250311 | CID_44250311 | |
| 0.051 | 0.075 | 0.059 | Ryanodine receptor antagonist | 0.059 0.041 CID_44250311 | CID_44250311 | |
| 0.041 | 0.071 | 0.064 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.064 0.031 CID_154699639 | CID_154699639 | |
| 0.056 | 0.086 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.051 CID_154699639 | CID_154699639 | |
| 0.081 | 0.112 | 0.108 | Adenylate kinase inhibitor | 0.108 0.055 CID_154699639 | CID_154699639 | |
| 0.083 | 0.114 | 0.109 | Cholesterol synthesis inhibitor | 0.097 0.091 CID_154699639 0.109 0.077 CID_44250311 | CID_44250311 | |
| 0.037 | 0.069 | 0.065 | Alcohol oxidase inhibitor | 0.065 0.032 CID_154699639 0.057 0.038 CID_44250311 | CID_154699639 | |
| 0.129 | 0.161 | 0.284 | Aldehyde oxidase inhibitor | 0.174 0.12 CID_154699639 0.284 0.071 CID_44250311 | CID_44250311 | |
| 0.071 | 0.105 | 0.091 | Estrogen-related receptor beta agonist | 0.077 0.076 CID_154699639 0.091 0.038 CID_44250311 | CID_44250311 | |
| 0.127 | 0.163 | 0.16 | Phospholipase C inhibitor | 0.16 0.088 CID_154699639 0.147 0.112 CID_44250311 | CID_154699639 | |
| 0.045 | 0.087 | 0.062 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 CID_44250311 | CID_44250311 | |
| 0.127 | 0.169 | 0.138 | Cyclin-dependent kinase 3 inhibitor | 0.138 0.128 CID_44250311 | CID_44250311 | |
| 0.112 | 0.157 | 0.142 | Interferon gamma antagonist | 0.142 0.089 CID_44250311 | CID_44250311 | |
| 0.039 | 0.085 | 0.062 | Dopamine agonist | 0.062 0.05 CID_44250311 | CID_44250311 | |
| 0.065 | 0.114 | 0.094 | Breast cancer-resistant protein inhibitor | 0.094 0.061 CID_44250311 | CID_44250311 | |
| 0.134 | 0.183 | 0.229 | Vasodilator | 0.229 0.083 CID_154699639 0.178 0.124 CID_44250311 | CID_154699639 | |
| 0.072 | 0.122 | 0.148 | Cystathionine beta-synthase inhibitor | 0.148 0.041 CID_44250311 | CID_44250311 | |
| 0.096 | 0.147 | 0.116 | DNA repair enzyme inhibitor | 0.116 0.081 CID_154699639 | CID_154699639 | |
| 0.079 | 0.131 | 0.124 | DOPA decarboxylase inhibitor | 0.124 0.041 CID_44250311 | CID_44250311 | |
| 0.032 | 0.087 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 CID_154699639 | CID_154699639 | |
| 0.023 | 0.079 | 0.032 | Tubulin agonist | 0.032 0.029 CID_154699796 | CID_154699796 | |
| 0.055 | 0.118 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.042 CID_44250311 | CID_44250311 | |
| 0.071 | 0.137 | 0.104 | Beta glucuronidase inhibitor | 0.093 0.081 CID_154699639 0.104 0.064 CID_44250311 | CID_44250311 | |
| 0.079 | 0.147 | 0.107 | Aldehyde dehydrogenase inhibitor | 0.107 0.087 CID_44250311 | CID_44250311 | |
| 0.039 | 0.109 | 0.069 | Histidine decarboxylase inhibitor | 0.069 0.051 CID_44250311 | CID_44250311 | |
| 0.034 | 0.105 | 0.064 | Phosphofructokinase-1 inhibitor | 0.064 0.053 CID_154699639 | CID_154699639 | |
| 0.112 | 0.185 | 0.15 | MAP kinase kinase 4 inhibitor | 0.15 0.062 CID_44250311 | CID_44250311 | |
| 0.082 | 0.156 | 0.122 | Thrombolytic | 0.122 0.108 CID_44250311 | CID_44250311 | |
| 0.033 | 0.108 | 0.077 | Opioid mu receptor antagonist | 0.077 0.041 CID_44250311 | CID_44250311 | |
| 0.069 | 0.145 | 0.143 | Amylase inhibitor | 0.143 0.068 CID_44250311 | CID_44250311 | |
| 0.034 | 0.113 | 0.111 | Antineoplastic antibiotic | 0.093 0.049 CID_154699639 0.111 0.041 CID_154699796 | CID_154699796 | |
| 0.051 | 0.133 | 0.097 | Opioid antagonist | 0.097 0.05 CID_44250311 | CID_44250311 | |
| 0.067 | 0.15 | 0.093 | Interleukin 1b antagonist | 0.093 0.09 CID_154699796 | CID_154699796 | |
| 0.024 | 0.114 | 0.067 | Opioid delta receptor antagonist | 0.067 0.042 CID_44250311 | CID_44250311 | |
| 0.035 | 0.129 | 0.064 | Transcription factor AP-1 inhibitor | 0.064 0.039 CID_154699796 | CID_154699796 | |
| 0.113 | 0.207 | 0.168 | Neurotrophic factor enhancer | 0.168 0.112 CID_44250311 | CID_44250311 | |
| 0.087 | 0.188 | 0.134 | Arachidonic acid antagonist | 0.134 0.108 CID_154699639 | CID_154699639 | |
| 0.095 | 0.203 | 0.142 | Melanin inhibitor | 0.142 0.094 CID_44250311 | CID_44250311 | |
| 0.047 | 0.16 | 0.08 | Alcohol dehydrogenase inhibitor | 0.08 0.079 CID_44250311 | CID_44250311 | |
| 0.044 | 0.198 | 0.125 | Topoisomerase II inhibitor | 0.125 0.063 CID_44250311 | CID_44250311 | |
| 0.12 | 0.275 | 0.191 | Hypoxia-inducible factor 1 alpha inhibitor | 0.191 0.163 CID_44250311 | CID_44250311 | |
| 0.086 | 0.244 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.091 CID_44250311 | CID_44250311 | |
| 0.045 | 0.22 | 0.103 | Tubulin antagonist | 0.103 0.099 CID_44250311 | CID_44250311 | |
| 0.128 | 0.332 | 0.202 | Apoptosis antagonist | 0.202 0.176 CID_44250311 | CID_44250311 | |
| 0.147 | 0.366 | 0.339 | Cyclophilin D inhibitor | 0.339 0.13 CID_154699639 | CID_154699639 | |
| 0.12 | 0.37 | 0.219 | Caspase 3 stimulant | 0.219 0.144 CID_44250311 | CID_44250311 | |
| 0.028 | 0.309 | 0.105 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 CID_154699796 | CID_154699796 | |
| 0.042 | 0.341 | 0.146 | Estrogen antagonist | 0.146 0.025 CID_44250311 | CID_44250311 | |
| 0.099 | 0.432 | 0.207 | Peptidyltransferase inhibitor | 0.207 0.091 CID_154699639 | CID_154699639 | |
| 0.038 | 0.47 | 0.133 | Nitric oxide antagonist | 0.133 0.114 CID_154699796 | CID_154699796 | |
| 0.019 | 0.477 | 0.124 | Estrogen receptor beta antagonist | 0.124 0.028 CID_44250311 | CID_44250311 | |
| 0.009 | 0.497 | 0.032 | Estrogen-related receptor beta antagonist | 0.032 0.022 CID_44250311 | CID_44250311 | |
| 0.03 | 0.54 | 0.188 | Antioxidant | 0.188 0.124 CID_44250311 | CID_44250311 | |
| 0.047 | 0.666 | 0.202 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 CID_154699639 | CID_154699639 | |
| 0.006 | 0.642 | 0.073 | Vanilloid 1 antagonist | 0.073 0.041 CID_154699639 | CID_154699639 | |
| 0.013 | 0.651 | 0.163 | Free radical scavenger | 0.163 0.131 CID_44250311 | CID_44250311 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |